Ellen F Foxman, MD, PhD
Associate Professor of Laboratory Medicine and ImmunobiologyCards
About
Titles
Associate Professor of Laboratory Medicine and Immunobiology
Biography
Dr. Ellen Foxman, M.D., PhD. is an Associate Professor of Laboratory Medicine and Immunobiology at the Yale School of Medicine. Her laboratory studies antiviral defense in the human respiratory tract, focusing on innate immunity, an inborn system of protective mechanisms that guards against harmful viruses or bacteria, even when the body has never encountered the infection before. The overarching goal of this research is to improve the diagnosis, treatment, and prevention of illnesses caused by respiratory viruses.
Background. Dr. Foxman trained in medicine and immunology at Stanford University. She became interested in respiratory viruses during her residency training in clinical pathology at Harvard's Brigham and Women's Hospital, due to the advances in testing that were beginning to reveal a previously unappreciated very high prevalence of these viruses. She later joined Dr. Akiko Iwasaki’s group at Yale as a postdoctoral associate, where she demonstrated suppression of innate immune responses in the airway epithelium by cool ambient temperature. In 2016, she established her independent research group at Yale. Contributions of the Foxman Lab include defining biomarkers to track innate immune responses in the human respiratory tract and uncovering evidence for viral interference, in which general antiviral defenses triggered by common cold viruses protect against unrelated viruses such as influenza and COVID-19. Dr. Foxman’s recognitions include the 2018 Hartwell Foundation Individual Biomedical Research Award, the 2021 ASCI Young Physician-Scientist Award, and the 2021 Rita Allen Foundation Scholars Award.
Appointments
Laboratory Medicine
Associate Professor on TermPrimaryImmunobiology
Associate Professor on TermSecondary
Other Departments & Organizations
- Cancer Signaling Networks
- Center for Infection and Immunity
- CPIRT - Center for Pulmonary Injury, Inflammation, Repair and Therapeutics
- Foxman Lab
- Human and Translational Immunology Program
- Immunobiology
- Immunology
- Laboratory Medicine
- Microbiology
- Virology Laboratories
- Yale Combined Program in the Biological and Biomedical Sciences (BBS)
- Yale Medicine
- YCCEH
Education & Training
- Resident in Clinical Pathology
- Brigham and Women's Hospital, Harvard Medical School (2004)
- MD
- Stanford University School of Medicine, Medicine (2001)
- PhD
- Stanford University School of Medicine, Immunology (1999)
- BS
- Yale University, Biology (1993)
Research
Overview
Background. Over the past decade, the improved technologies for detecting respiratory viruses have revealed that respiratory virus infections are much more frequent than previously appreciated, and that the same viral infection can have a range of outcomes ranging from asymptomatic to serious lung disease. To understand the molecular mechanisms that govern susceptibility to respiratory viruses, study the cell-intrinsic innate immune defenses of the target cells in which these viruses replicate, the epithelial cells that from the lining of the airway.
Impact of recent exposures on antiviral defense.
Viral interference. Respiratory viruses spread through the population in epidemic waves every year, but the forces shaping the timing of these epidemics are not completely understood. Recently, we showed that infection with rhinovirus, the common cold virus, can provide temporary protection against infection with influenza A virus by activating broad antiviral defenses (the interferon response) within airway epithelial cells (Wu and Mihalyova et al, The Lancet Microbe, 2020). This observation fits with epidemiological data showing staggered seasonal epidemics of rhinovirus and influenza A every year, and the observation that the annual autumn rhinovirus season appeared to delay the swine flu epidemic in Europe in 2009.
Oxidative stress. A broad theme emerging from our studies of epithelial innate immune mechanisms is that environmental factors which impact epithelial cell biology can modulate antiviral defenses and alter the course of infection. In several studies, we have observed an impact of certain environmental exposures on defense against rhinovirus, the most frequent cause of the common cold and the #1 trigger of childhood asthma attacks. In recent work, we found that recognition of cytoplasmic viral RNA within airway epithelial cells triggers both the expected antiviral interferon response and a defense response against oxidative stress mediated by the transcription factor NRF2. Further investigation showed that increasing NRF2 activation dampened antiviral signaling, indicating a tradeoff between these two defense responses. We also observed differences in calibration of these protective responses in epithelial stem cells from different regions of the airway (nasal vs. lung). This work indicates that the airway epithelium can adapt and survive when encountering oxidative airway damage, this leaves the epithelium more vulnerable to rhinovirus infection. (Mihaylova et al, Cell Reports, 2018).
Cool temperature. This theme also fits with discoveries from my post-doctoral fellowship, in which our team showed that cool temperature can alter the ability of the airway cells to mount an effective innate immune response against rhinovirus. We discovered that mechanisms used by the innate immune system to protect cells against this virus are quite effective at core body temperature (37°C), but are diminished at slightly cooler temperatures, such as temperatures that might be found in the nasal passages upon inhaling cool ambient air (33°C). (Foxman et al, PNAS, 2015 and Foxman et al, PNAS, 2016). The temperature-dependent signals identified in this study are important in immune defense against many viruses, and these findings suggest that cool areas of the body may provide a niche for certain viruses to evade antiviral defenses.
Studying host response viral infection in vivo in humans. Informed by my experiences as a clinical pathologist, my laboratory has also initiated projects to study host responses to airway infections using clinical samples. In a collaborative project, we recently found that measuring mRNAs and proteins induced by the local airway antiviral interferon response can accurately identify patients with respiratory virus infection using nasopharyngeal swabs (Landry and Foxman, Journal of Infectious Diseases, 2018.)
Medical Research Interests
Public Health Interests
Academic Achievements & Community Involvement
Clinical Care
Overview
Clinical Specialties
Fact Sheets
Colds: How to Prevent Them
Learn More on Yale Medicine
Board Certifications
Clinical Pathology
- Certification Organization
- AB of Pathology
- Original Certification Date
- 2004
Yale Medicine News
News & Links
News
- November 19, 2024Source: Yale Daily News
Yale experts explain Lassa fever
- July 11, 2024Source: Yale Ventures
11 Yale Projects Receive Awards from the Colton Center for Autoimmunity
- July 01, 2024Source: Channel 8 news
Why did so few children get sick from COVID-19?
- July 01, 2024Source: Yale News
Kids’ Susceptibility to Seasonal Viruses May Protect Them From COVID-19